Spetzler David Baxley - Insider Non-Derivative Transactions at Caris Life Sciences, Inc. (CAI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 7, 2025, Spetzler David Baxley's relationship to Caris Life Sciences, Inc. (CAI) is Officer (President), and currently has 460,777 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CAI insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Spetzler David Baxley - Insider Non-Derivative Transactions of CAI Common Stock

Spetzler David Baxley - Insider Non-Derivative Transactions at CAI

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 8, 2025	P -- (Common Stock)	400	23.85	460777
Aug 12, 2025	F -- (Common Stock)	63509	29.75	460377
Jun 21, 2025	F -- (Common Stock)	34782	27.25	523886
Jun 21, 2025	M -- (Common Stock)	75000	2.44	558668
Jun 19, 2025	Acquisition -- (Common Stock)	132428	0	483668
Mar 4, 2025	Disposition -- (Common Stock)	700509	18.6	351240